Cell-type-specific	O
transactivation	O
of	O
the	O
parathyroid	B-DNA
hormone-related	I-DNA
protein	I-DNA
gene	I-DNA
promoter	I-DNA
by	O
the	O
human	B-protein
T-cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
I	I-protein
(	I-protein
HTLV-I	I-protein
)	I-protein
tax	I-protein
and	O
HTLV-II	B-protein
tax	I-protein
proteins	I-protein
.	O

The	O
human	B-protein
T-cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
I	I-protein
(	I-protein
HTLV-I	I-protein
)	I-protein
and	I-protein
HTLV-II	I-protein
Tax	I-protein
proteins	I-protein
are	O
potent	O
transactivators	B-protein
of	O
viral	O
and	O
cellular	O
gene	O
expression	O
.	O

Using	O
deletion	B-DNA
mutants	I-DNA
,	O
the	O
downstream	O
parathyroid	B-DNA
hormone-related	I-DNA
protein	I-DNA
(	I-DNA
PTHrP	I-DNA
)	I-DNA
promoter	I-DNA
is	O
shown	O
to	O
be	O
responsive	O
to	O
both	O
HTLV-I	B-protein
and	I-protein
HTLV-II	I-protein
Tax	I-protein
as	O
well	O
as	O
the	O
AP1/c-jun	B-DNA
proto-oncogene	I-DNA
.	O

Transactivation	O
of	O
PTHrP	B-protein
by	O
Tax	B-protein
was	O
seen	O
in	O
T	B-cell_type
cells	I-cell_type
but	O
not	O
in	O
B-cell	B-cell_line
lines	I-cell_line
or	O
fibroblasts	B-cell_line
.	O

A	O
carboxy	B-DNA
terminal	I-DNA
Tax	I-DNA
deletion	I-DNA
mutant	I-DNA
was	O
deficient	O
in	O
transactivation	O
of	O
both	O
the	O
PTHrP	B-DNA
and	I-DNA
IL2R	I-DNA
alpha	I-DNA
promoters	I-DNA
but	O
not	O
the	O
HTLV-I	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
.	O

Exogenous	O
provision	O
of	O
NFkB	B-protein
rescued	O
IL2R	B-protein
alpha	O
expression	O
but	O
not	O
the	O
PTHrP	B-DNA
promoter	I-DNA
.	O

Thus	O
,	O
HTLV-I	B-protein
Tax	I-protein
,	O
HTLV-II	B-protein
Tax	I-protein
,	O
and	O
c-jun	B-protein
transactivate	O
PTHrP	B-protein
and	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
hypercalcemia	O
in	O
adult	O
T-cell	O
leukemia	O
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Cell-Type-Specific	NULL
Transactivation	NULL
of	NULL
the	NULL
Parathyroid	NULL
Hormone-Related	NULL
Protein	NULL
Gene	NULL
Promoter	NULL
by	NULL
the	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
Tax	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
Proteins	NULL
By	NULL
Eri	NULL
Ejima	NULL
,	NULL
Joseph	NULL
D.	NULL
Rosenblatt	NULL
,	NULL
Mark	NULL
Massari	NULL
,	NULL
Eddie	NULL
Quan	NULL
,	NULL
Dennis	NULL
Stephens	NULL
,	NULL
Craig	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
Diane	NULL
Prager	NULL
The	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
proteins	NULL
are	NULL
potent	NULL
transactivators	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
gene	NULL
expression	NULL
.	NULL

Using	NULL
deletion	NULL
mutants	NULL
,	NULL
the	NULL
downstream	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
(	NULL
PTHrP	NULL
)	NULL
promoter	NULL
is	NULL
shown	NULL
to	NULL
be	NULL
responsive	NULL
to	NULL
both	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
as	NULL
well	NULL
as	NULL
the	NULL
AP1/c-jun	NULL
proto-oncogene	NULL
.	NULL

Transactivation	NULL
of	NULL
PTHrP	NULL
by	NULL
Tax	NULL
was	NULL
seen	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
B-cell	NULL
lines	NULL
or	NULL
fibroblasts	NULL
.	NULL

A	NULL
carboxy	NULL
terminal	NULL
Tax	NULL
deletion	NULL
mutant	NULL
was	NULL
OST	NULL
PATIENTS	NULL
with	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
,	NULL
associated	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
infection	NULL
develop	NULL
hypercalcemia	NULL
.	NULL

Human	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
(	NULL
PTHrP	NULL
)	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
humoral	NULL
hypercalcemia	NULL
associated	NULL
with	NULL
certain	NULL
solid	NULL
tumors	NULL
.	NULL

'*	NULL
Recent	NULL
studies	NULL
have	NULL
shown	NULL
constitutive	NULL
expression	NULL
of	NULL
PTHrP	NULL
by	NULL
malignant	NULL
cells	NULL
derived	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
asymptomatic	NULL
HTLV-I	NULL
carriers	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
ascitic	NULL
and	NULL
pleural	NULL
fluid	NULL
from	NULL
patients	NULL
with	NULL
ATL	NULL
have	NULL
detectable	NULL
levels	NULL
of	NULL
PTHrP	NULL
.	NULL
``	NULL

HTLV-I	NULL
appears	NULL
to	NULL
induce	NULL
transformation	NULL
by	NULL
a	NULL
novel	NULL
mechanism	NULL
because	NULL
it	NULL
does	NULL
not	NULL
encode	NULL
a	NULL
known	NULL
oncogene	NULL
product	NULL
and	NULL
it	NULL
integrates	NULL
randomly	NULL
within	NULL
the	NULL
host	NULL
genome	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
structural	NULL
proteins	NULL
,	NULL
the	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
genomes	NULL
encode	NULL
two	NULL
unique	NULL
proteins	NULL
,	NULL
Tax	NULL
and	NULL
Rex	NULL
.	NULL
``	NULL

Rex	NULL
is	NULL
a	NULL
27-Kd	NULL
nuclear	NULL
protein	NULL
that	NULL
controls	NULL
cytoplasmic	NULL
expression	NULL
of	NULL
unspliced	NULL
and	NULL
partially	NULL
spliced	NULL
intermediate	NULL
viral	NULL
messenger	NULL
RNAs	NULL
(	NULL
mRNAs	NULL
)	NULL
.	NULL

Tax	NULL
is	NULL
a	NULL
40-Kd	NULL
nuclear	NULL
phosphoprotein	NULL
in	NULL
HTLV-I	NULL
,	NULL
and	NULL
a	NULL
37	NULL
Kd	NULL
nuclear	NULL
phosphoprotein	NULL
in	NULL
HTLV-II	NULL
,	NULL
respectively	NULL
.	NULL

Tax	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
long	NULL
terminal	NULL
repeats	NULL
(	NULL
LTRs	NULL
)	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Furthermore	NULL
,	NULL
Tax	NULL
transactivates	NULL
numerous	NULL
cellular	NULL
genes	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
Tax	NULL
has	NULL
been	NULL
thought	NULL
to	NULL
contribute	NULL
to	NULL
T-cell	NULL
transformation	NULL
by	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
and	NULL
,	NULL
by	NULL
inference	NULL
,	NULL
to	NULL
early	NULL
leukemo-genesis	NULL
.	NULL

Tax	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
directly	NULL
but	NULL
rather	NULL
activates	NULL
transcription	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
through	NULL
interaction	NULL
with	NULL
other	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
cAMP	NULL
response	NULL
element-binding	NULL
proteins	NULL
or	NULL
NFkB	NULL
.	NULL

Tax	NULL
responsive	NULL
sequences	NULL
on	NULL
the	NULL
c-fos	NULL
,	NULL
proenkephalin	NULL
,	NULL
nerve	NULL
growth	NULL
factor	NULL
,	NULL
EGR-1	NULL
promoters	NULL
,	NULL
and	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
LTRs	NULL
all	NULL
contain	NULL
the	NULL
TGACGTCT	NULL
octamer	NULL
core	NULL
element	NULL
suggesting	NULL
that	NULL
Tax	NULL
transactivation	NULL
of	NULL
these	NULL
genes	NULL
may	NULL
occur	NULL
through	NULL
interaction	NULL
with	NULL
similar	NULL
host	NULL
transcription	NULL
factors	NULL
.	NULL
``	NULL

''	NULL
In	NULL
contrast	NULL
,	NULL
Tax	NULL
induction	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
,	NULL
and	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
(	NULL
IL-2	NULL
Ra	NULL
)	NULL
genes	NULL
involves	NULL
induced	NULL
nuclear	NULL
expression	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
NF	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
.	NULL
``	NULL

''	NULL
The	NULL
PTHrP	NULL
promoter	NULL
has	NULL
also	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
transactivated	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
the	NULL
promoter	NULL
does	NULL
not	NULL
contain	NULL
NFB	NULL
sequences	NULL
and	NULL
only	NULL
has	NULL
a	NULL
single	NULL
cyclic	NULL
AMP	NULL
responsive	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
-like	NULL
element	NULL
.	NULL

The	NULL
studies	NULL
presented	NULL
here	NULL
further	NULL
extend	NULL
this	NULL
initial	NULL
observation	NULL
by	NULL
showing	NULL
that	NULL
both	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
transactivate	NULL
the	NULL
PTHrP	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
B-cell	NULL
lines	NULL
,	NULL
and	NULL
that	NULL
the	NULL
carboxy	NULL
terminal	NULL
domain	NULL
of	NULL
Tax	NULL
required	NULL
for	NULL
IL2Ra	NULL
but	NULL
not	NULL
for	NULL
HTLV-I	NULL
LTR	NULL
transactivation	NULL
,	NULL
is	NULL
also	NULL
required	NULL
for	NULL
transactivation	NULL
of	NULL
PTHrP	NULL
,	NULL
although	NULL
distinct	NULL
mechanisms	NULL
may	NULL
be	NULL
involved	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
81	NULL
,	NULL
No	NULL
4	NULL
(	NULL
February	NULL
15	NULL
)	NULL
,	NULL
1993	NULL
:	NULL
pp	NULL
1017-1024	NULL
deficient	NULL
in	NULL
transactivation	NULL
of	NULL
both	NULL
the	NULL
PTHrP	NULL
and	NULL
IL2Ra	NULL
promoters	NULL
but	NULL
not	NULL
the	NULL
HTLV-I	NULL
long	NULL
terminal	NULL
repeat	NULL
{	NULL
LTR	NULL
}	NULL
.	NULL

Exogenous	NULL
provision	NULL
of	NULL
NFKB	NULL
rescued	NULL
expression	NULL
but	NULL
not	NULL
the	NULL
PTHrP	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
HTLV-I	NULL
Tax	NULL
,	NULL
HTLV-II	NULL
Tax	NULL
,	NULL
and	NULL
c-jun	NULL
transactivate	NULL
PTHrP	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
hypercalcemia	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
.	NULL

All	NULL
restriction	NULL
and	NULL
DNA	NULL
modifying	NULL
enzymes	NULL
were	NULL
purchased	NULL
from	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
(	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

[	NULL
``	NULL
C	NULL
]	NULL
chloramphenicol	NULL
and	NULL
{	NULL
a-P	NULL
]	NULL
dNTP	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
(	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

MLA	NULL
144	NULL
T	NULL
cells	NULL
,	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
729	NULL
pH6neo	NULL
cells	NULL
``	NULL
``	NULL
were	NULL
maintained	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

ATL	NULL
1K	NULL
cells	NULL
(	NULL
mutant	NULL
HTLV-I	NULL
genome	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
Iscove	NULL
's	NULL
medium	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
.	NULL

MT2	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
Rat	NULL
1	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
e-minimum	NULL
essential	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Medium	NULL
contained	NULL
50	NULL
U/mL	NULL
penicillin	NULL
,	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
L-glu-tamine	NULL
.	NULL

Plasmids	NULL
.	NULL

A	NULL
2,784bp	NULL
Hindlll/Ase	NULL
I	NULL
fragment	NULL
containing	NULL
the	NULL
downstream	NULL
human	NULL
PTHrP	NULL
promoter	NULL
was	NULL
isolated	NULL
from	NULL
clone	NULL
SH	NULL
1	NULL
.	NULL
``	NULL

The	NULL
ends	NULL
were	NULL
blunted	NULL
with	NULL
dNTPs	NULL
and	NULL
klenow	NULL
and	NULL
the	NULL
fragment	NULL
ligated	NULL
into	NULL
the	NULL
end-filled	NULL
Xba	NULL
I	NULL
site	NULL
in	NULL
the	NULL
polylinker	NULL
of	NULL
CATMS4PA	NULL
to	NULL
generate	NULL
-2673PTHrPCAT	NULL
.	NULL

To	NULL
generate	NULL
deletion	NULL
constructs	NULL
of	NULL
the	NULL
PTHrP	NULL
promoter	NULL
,	NULL
the	NULL
HindIlI/Ase	NULL
I	NULL
fragment	NULL
was	NULL
digested	NULL
with	NULL
Xba	NULL
I	NULL
,	NULL
Nsi	NULL
I	NULL
,	NULL
Avr	NULL
II	NULL
,	NULL
and	NULL
Ace	NULL
I	NULL
.	NULL

Each	NULL
fragment	NULL
was	NULL
gel	NULL
isolated	NULL
and	NULL
ligated	NULL
into	NULL
CATMS4PA	NULL
.	NULL

The	NULL
deletion	NULL
constructs	NULL
were	NULL
named	NULL
-1498PTHrPCAT	NULL
,	NULL
-862PTHrPCAT	NULL
,	NULL
-329PTHrPCAT	NULL
,	NULL
-	NULL
and	NULL
-45PTHrPCAT	NULL
,	NULL
respectively	NULL
to	NULL
indicate	NULL
the	NULL
length	NULL
of	NULL
the	NULL
5°	NULL
DNA	NULL
relative	NULL
to	NULL
the	NULL
exon	NULL
2	NULL
start	NULL
site	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
sequenced	NULL
to	NULL
confirm	NULL
their	NULL
identity	NULL
by	NULL
polymerase	NULL
T	NULL
;	NULL
(	NULL
US	NULL
Biochemicals	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

The	NULL
HTLV-I	NULL
Tax/Rex	NULL
expression	NULL
vector	NULL
,	NULL
BC3.9	NULL
,	NULL
*	NULL
and	NULL
HTLV-II	NULL
Tax/Rex	NULL
expression	NULL
vector	NULL
,	NULL
BC20.2*	NULL
are	NULL
subcloned	NULL
in	NULL
a	NULL
cytomeg-alovirus	NULL
(	NULL
CMV	NULL
)	NULL
-based	NULL
vector	NULL
BC12*	NULL
as	NULL
described	NULL
.	NULL

BC3.9	NULL
Sph	NULL
and	NULL
BC20.2	NULL
Sph	NULL
vectors	NULL
(	NULL
Tax	NULL
only	NULL
)	NULL
lack	NULL
the	NULL
rex	NULL
methionine	NULL
initiation	NULL
codon	NULL
.	NULL
``	NULL

Tax	NULL
A984	NULL
contains	NULL
a	NULL
30	NULL
carboxy	NULL
terminal	NULL
amino	NULL
acid	NULL
dele-	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Endocrinology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Hematology-Oncology	NULL
and	NULL
UCLA	NULL
AIDS	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
and	NULL
Johnson	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
;	NULL
and	NULL
the	NULL
Roche	NULL
Institute	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
.	NULL

Submitted	NULL
July	NULL
13	NULL
,	NULL
1992	NULL
;	NULL
accepted	NULL
October	NULL
14	NULL
,	NULL
1992	NULL
.	NULL

D.P	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
)	NULL
Grants	NULL
No	NULL
.	NULL

DK02023	NULL
and	NULL
DK47292	NULL
.	NULL

J.D.R	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
NIH	NULL
Awards	NULL
CA52410	NULL
,	NULL
CA	NULL
53632	NULL
,	NULL
CA	NULL
32737	NULL
;	NULL
NIH	NULL
Shannon	NULL
Award	NULL
CA	NULL
04718	NULL
;	NULL
and	NULL
USAMRDC	NULL
Contract	NULL
No	NULL
.	NULL

DAMD	NULL
17-91-C-1001	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Diane	NULL
Prager	NULL
,	NULL
MD	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
Endocrinology	NULL
,	NULL
Becker	NULL
Building	NULL
B131	NULL
,	NULL
8700	NULL
Beverly	NULL
Blvd	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90048	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/93/8104-0003	NULL
$	NULL
3.00/0	NULL
1017	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1018	NULL
tion	NULL
.	NULL
``	NULL

A	NULL
p50/p65	NULL
NFxB	NULL
fusion	NULL
protein	NULL
expression	NULL
plasmid	NULL
was	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

'	NULL
The	NULL
1L2R	NULL
&	NULL
CAT*	NULL
HTLV-I	NULL
LTRCAT	NULL
,	NULL
``	NULL
and	NULL
c-jun	NULL
expression	NULL
``	NULL
``	NULL
vectors	NULL
were	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

Transfection	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

-	NULL
Plasmid	NULL
DNA	NULL
used	NULL
for	NULL
transfection	NULL
was	NULL
prepared	NULL
on	NULL
two	NULL
CsCl	NULL
;	NULL
gradients	NULL
.	NULL

MLA	NULL
144	NULL
T	NULL
cells	NULL
,	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
729pH6neo	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
in	NULL
duplicate	NULL
by	NULL
electroporation	NULL
(	NULL
Biorad	NULL
Laboratories	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
plasmid	NULL
at	NULL
250V	NULL
and	NULL
960uF	NULL
in	NULL
250	NULL
LL	NULL
of	NULL
1.2	NULL
%	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

>	NULL
Rat	NULL
1	NULL
cells	NULL
were	NULL
transfected	NULL
in	NULL
duplicate	NULL
in	NULL
OPTI-MEM-1	NULL
medium	NULL
using	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

The	NULL
plasmid	NULL
BC12	NULL
was	NULL
added	NULL
as	NULL
required	NULL
to	NULL
standardize	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

After	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
for	NULL
48	NULL
hours	NULL
,	NULL
and	NULL
then	NULL
harvested	NULL
into	NULL
0.01	NULL
mol/L	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Cell	NULL
membranes	NULL
were	NULL
disrupted	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
,	NULL
and	NULL
protein	NULL
concentrations	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
.	NULL
``	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
extract	NULL
were	NULL
incubated	NULL
with	NULL
[	NULL
'*C	NULL
)	NULL
chloramphenicol	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Acetylated	NULL
and	NULL
nonacetylated	NULL
spots	NULL
were	NULL
cut	NULL
from	NULL
the	NULL
chromatography	NULL
paper	NULL
and	NULL
quantitated	NULL
by	NULL
liquid	NULL
scintillation	NULL
counting	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
as	NULL
percentage	NULL
of	NULL
acetylation	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

-	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
the	NULL
guani-dinium-thiocyanate	NULL
method	NULL
.	NULL
``	NULL

''	NULL
Total	NULL
RNA	NULL
(	NULL
60	NULL
ug	NULL
)	NULL
was	NULL
separated	NULL
by	NULL
electrophoresis	NULL
through	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membrane	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
[	NULL
**P	NULL
cDNA	NULL
probes	NULL
(	NULL
PTHrP	NULL
,	NULL
y-actin	NULL
)	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
random	NULL
priming	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
at	NULL
-70°C	NULL
with	NULL
intensifying	NULL
screens	NULL
.	NULL
``	NULL

RESULTS	NULL
Transactivation	NULL
of	NULL
the	NULL
human	NULL
PTHrP	NULL
promoter	NULL
by	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
.	NULL

-	NULL
HTLV	NULL
T	NULL
cells	NULL
constitutively	NULL
express	NULL
PTHrP	NULL
,	NULL
suggesting	NULL
that	NULL
Tax	NULL
might	NULL
transactivate	NULL
the	NULL
PTHrP	NULL
promoter	NULL
.	NULL
``	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
human	NULL
PTHrP	NULL
promoter	NULL
deletion	NULL
mutant	NULL
CAT	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
constructs	NULL
were	NULL
transiently	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
together	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
either	NULL
HTLV-I	NULL
Tax	NULL
(	NULL
BC3.9	NULL
sph	NULL
)	NULL
or	NULL
HTLV-II	NULL
Tax	NULL
(	NULL
BC20.2	NULL
sph	NULL
)	NULL
.	NULL

Using	NULL
gibbon	NULL
T	NULL
cells	NULL
(	NULL
MLA-144	NULL
)	NULL
as	NULL
the	NULL
recipient	NULL
cell	NULL
line	NULL
,	NULL
HTLV-I	NULL
Tax	NULL
(	NULL
BC3.9	NULL
sph	NULL
)	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
(	NULL
BC20.2	NULL
sph	NULL
)	NULL
transactivated	NULL
all	NULL
the	NULL
deletion	NULL
mutants	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

The	NULL
highest	NULL
levels	NULL
of	NULL
induction	NULL
were	NULL
seen	NULL
with	NULL
the	NULL
-2673PTHrPCAT	NULL
and	NULL
-1498PTHrPCAT	NULL
constructs	NULL
.	NULL

All	NULL
PTHrP	NULL
promoter	NULL
CAT	NULL
deletion	NULL
mutants	NULL
were	NULL
similarly	NULL
transactivated	NULL
by	NULL
HTLV-I	NULL
Tax/Rex	NULL
and	NULL
HTLV-II	NULL
Tax/Rex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
was	NULL
significantly	NULL
more	NULL
active	NULL
in	NULL
transactivating	NULL
-45PTHrPCAT	NULL
than	NULL
HTLV-II	NULL
Tax	NULL
.	NULL

Although	NULL
the	NULL
exact	NULL
mechanism	NULL
for	NULL
this	NULL
difference	NULL
needs	NULL
to	NULL
be	NULL
examined	NULL
,	NULL
differential	NULL
transactivation	NULL
of	NULL
the	NULL
human	NULL
EGR-1	NULL
promoter	NULL
by	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
has	NULL
been	NULL
described	NULL
.	NULL
``	NULL

The	NULL
carboxy	NULL
terminal	NULL
acidic	NULL
portion	NULL
of	NULL
Tax	NULL
is	NULL
required	NULL
for	NULL
PTHrP	NULL
transactivation	NULL
.	NULL

_	NULL
Several	NULL
studies	NULL
of	NULL
other	NULL
promoters	NULL
indicate	NULL
that	NULL
Tax	NULL
may	NULL
transactivate	NULL
viral	NULL
or	NULL
cellular	NULL
gene	NULL
expression	NULL
through	NULL
induced	NULL
interactions	NULL
with	NULL
either	NULL
NFx	NULL
«	NULL
B	NULL
or	NULL
cAMP	NULL
responsive	NULL
sequences	NULL
(	NULL
CREs	NULL
)	NULL
.	NULL
``	NULL

''	NULL
The	NULL
downstream	NULL
human	NULL
PTHrP	NULL
gene	NULL
promoter	NULL
contains	NULL
no	NULL
NF	NULL
«	NULL
B-like	NULL
sequences	NULL
or	NULL
classical	NULL
CREs	NULL
.	NULL

However	NULL
,	NULL
a	NULL
CRE-like	NULL
sequence	NULL
,	NULL
TGACTTCA	NULL
,	NULL
with	NULL
seven	NULL
out	NULL
of	NULL
eight	NULL
homologous	NULL
base	NULL
pairs	NULL
is	NULL
located	NULL
at	NULL
+32/+40	NULL
.	NULL

Ruben	NULL
et	NULL
al	NULL
``	NULL
``	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
amino	NULL
or	NULL
internal	NULL
region	NULL
Tax	NULL
protein	NULL
mutations	NULL
inhibit	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
transactivate	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
and	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
30	NULL
carboxy	NULL
terminal	NULL
amino	NULL
acids	NULL
results	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
HTLV-I	NULL
Tax	NULL
transactivation	NULL
of	NULL
the	NULL
1L-2Ra	NULL
pro	NULL
EJIMA	NULL
ET	NULL
AL	NULL
moter	NULL
but	NULL
not	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL
``	NULL

Provision	NULL
of	NULL
exogenous	NULL
p65/p50	NULL
NF	NULL
«	NULL
B®	NULL
'	NULL
in	NULL
the	NULL
form	NULL
of	NULL
a	NULL
fusion	NULL
protein	NULL
stimulates	NULL
the	NULL
1L-2Ra	NULL
gene	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
NFkB	NULL
pathway	NULL
is	NULL
mediating	NULL
Tax	NULL
transactivation	NULL
of	NULL
1L-2Ra	NULL
.	NULL

To	NULL
examine	NULL
which	NULL
domains	NULL
of	NULL
the	NULL
Tax	NULL
protein	NULL
might	NULL
be	NULL
mediating	NULL
transactivation	NULL
of	NULL
the	NULL
PTHrP	NULL
promoter	NULL
,	NULL
Tax	NULL
A984	NULL
,	NULL
a	NULL
mutant	NULL
with	NULL
a	NULL
30	NULL
amino	NULL
acid	NULL
deletion	NULL
of	NULL
the	NULL
carboxy	NULL
terminus	NULL
,	NULL
was	NULL
compared	NULL
with	NULL
wild-type	NULL
Tax	NULL
in	NULL
cotransfection	NULL
assays	NULL
.	NULL

As	NULL
positive	NULL
controls	NULL
for	NULL
the	NULL
study	NULL
,	NULL
we	NULL
used	NULL
both	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
and	NULL
HTLV-I	NULL
LTR	NULL
linked	NULL
to	NULL
CAT	NULL
reporter	NULL
genes	NULL
.	NULL

Cotransfection	NULL
of	NULL
LTR-1CAT	NULL
with	NULL
Tax	NULL
A984	NULL
resulted	NULL
in	NULL
similar	NULL
levels	NULL
of	NULL
transactivation	NULL
as	NULL
seen	NULL
with	NULL
the	NULL
intact	NULL
Tax	NULL
protein	NULL
expressed	NULL
by	NULL
BC	NULL
3.9	NULL
.	NULL

(	NULL
Fig	NULL
2	NULL
)	NULL
In	NULL
contrast	NULL
,	NULL
I	NULL
L-2R	NULL
«	NULL
CAT	NULL
activation	NULL
was	NULL
present	NULL
with	NULL
wild-type	NULL
Tax	NULL
(	NULL
BC	NULL
3.9	NULL
)	NULL
cotransfection	NULL
,	NULL
but	NULL
absent	NULL
with	NULL
Tax	NULL
A984	NULL
.	NULL

Cotransfection	NULL
of	NULL
1L-2Ra	NULL
«	NULL
CAT	NULL
with	NULL
the	NULL
p65/p50	NULL
NFxB	NULL
expression	NULL
vector	NULL
resulted	NULL
in	NULL
marked	NULL
induction	NULL
of	NULL
1L-2Ra	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
When	NULL
-2673PTHrPCAT	NULL
activation	NULL
was	NULL
tested	NULL
,	NULL
the	NULL
Tax	NULL
A984	NULL
deletion	NULL
mutant	NULL
showed	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
transactivation	NULL
compared	NULL
with	NULL
wild-type	NULL
Tax	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
NF	NULL
«	NULL
B	NULL
on	NULL
IL-2Ra	NULL
«	NULL
CAT	NULL
,	NULL
provision	NULL
of	NULL
exogenous	NULL
NFkB	NULL
was	NULL
unable	NULL
to	NULL
rescue	NULL
-2673PTHrPCAT	NULL
expression	NULL
.	NULL

Tax	NULL
A984	NULL
also	NULL
failed	NULL
to	NULL
transactivate	NULL
the	NULL
PTHrPCAT	NULL
promoter	NULL
deletion	NULL
mutants	NULL
to	NULL
similar	NULL
levels	NULL
seen	NULL
with	NULL
wild-type	NULL
Tax	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

c-jun	NULL
-	NULL
fransactivates	NULL
|	NULL
the-	NULL
human	NULL
-	NULL
PTHrP	NULL
promoter	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
the	NULL
c-jun	NULL
transcription	NULL
factor	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
in	NULL
HTLV-I	NULL
infected	NULL
cells	NULL
.	NULL
``	NULL

Because	NULL
the	NULL
PTHrP	NULL
promoter	NULL
contains	NULL
AP-1	NULL
recognition	NULL
sequences	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Tax	NULL
may	NULL
transactivate	NULL
the	NULL
PTHrP	NULL
promoter	NULL
via	NULL
induction	NULL
of	NULL
c-jun	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
cotransfection	NULL
studies	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
and	NULL
a	NULL
c-jun	NULL
expression	NULL
vector	NULL
were	NULL
performed	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

c-jun	NULL
(	NULL
0.5	NULL
to	NULL
4	NULL
ug	NULL
)	NULL
augmented	NULL
the	NULL
already	NULL
marked	NULL
Tax	NULL
induction	NULL
of	NULL
-2673PTHrPCAT	NULL
expression	NULL
,	NULL
whereas	NULL
c-Jun	NULL
alone	NULL
induced	NULL
-2673PTHrPCAT	NULL
expression	NULL
by	NULL
greater	NULL
than	NULL
100-fold	NULL
.	NULL

This	NULL
potent	NULL
induction	NULL
of	NULL
-2673PTHrPCAT	NULL
activity	NULL
by	NULL
c-jun	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
additive	NULL
effect	NULL
seen	NULL
with	NULL
Tax	NULL
,	NULL
suggests	NULL
that	NULL
Tax	NULL
and	NULL
c-jun	NULL
transactivation	NULL
of	NULL
PTHrPCAT	NULL
may	NULL
involve	NULL
the	NULL
same	NULL
pathway	NULL
.	NULL

Cotransfection	NULL
of	NULL
-2673PTHrPCAT	NULL
and	NULL
c-jun	NULL
into	NULL
MLA	NULL
T-cells	NULL
,	NULL
729	NULL
B-cells	NULL
,	NULL
or	NULL
Rat	NULL
1	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
.	NULL

The	NULL
HTLV-I	NULL
LTR	NULL
served	NULL
as	NULL
the	NULL
positive	NULL
control	NULL
.	NULL

Interestingly	NULL
,	NULL
marked	NULL
c-jun	NULL
transactivation	NULL
of	NULL
-2673PTHrPCAT	NULL
was	NULL
observed	NULL
in	NULL
T	NULL
cells	NULL
with	NULL
no	NULL
induction	NULL
in	NULL
fibroblasts	NULL
.	NULL

c-jun	NULL
cotransfaction	NULL
produced	NULL
a	NULL
small	NULL
induction	NULL
of	NULL
-2673PTHrPCAT	NULL
expression	NULL
in	NULL
729	NULL
B	NULL
cells	NULL
.	NULL

729	NULL
B	NULL
cells	NULL
constitutively	NULL
express	NULL
c-jun	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
so	NULL
that	NULL
additional	NULL
exogenous	NULL
c-Jun	NULL
would	NULL
not	NULL
be	NULL
expected	NULL
to	NULL
produce	NULL
a	NULL
marked	NULL
increment	NULL
in	NULL
PTHrPCAT	NULL
expression	NULL
.	NULL

c-jun	NULL
transactivation	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
was	NULL
observed	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
fibroblasts	NULL
,	NULL
and	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Tax	NULL
transactivation	NULL
of	NULL
the	NULL
PTHrP	NULL
promoter	NULL
requires	NULL
a	NULL
lymphoid-specific	NULL
factor	NULL
.	NULL

-	NULL
Because	NULL
the	NULL
PTHrP	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
many	NULL
different	NULL
tissues	NULL
,	NULL
``	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
Tax	NULL
is	NULL
cell	NULL
specific	NULL
.	NULL

-2673PTHrPCAT	NULL
was	NULL
transiently	NULL
cotransfected	NULL
together	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
into	NULL
729	NULL
B	NULL
cells	NULL
or	NULL
a	NULL
rat	NULL
fibroblast	NULL
cell	NULL
line	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
be	NULL
transactivated	NULL
by	NULL
Tax	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
was	NULL
similarly	NULL
cotransfected	NULL
with	NULL
Tax	NULL
.	NULL

In	NULL
both	NULL
the	NULL
rat	NULL
fibroblast-cell	NULL
line	NULL
(	NULL
Rat	NULL
1	NULL
)	NULL
and	NULL
human	NULL
B-cell	NULL
line	NULL
729	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
,	NULL
no	NULL
induction	NULL
of	NULL
PTHrP	NULL
promoter	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PTHaP	NULL
PROMOTER	NULL
TRANSACTIVATION	NULL
1019	NULL
EBS	NULL
AP2	NULL
SP1	NULL
AP1	NULL
A	NULL
AP1	NULL
AP2	NULL
«	NULL
2673	NULL
SP1	NULL
AP2	NULL
AP2	NULL
PTHrP-CAT	NULL
+1498	NULL
CAT	NULL
80	NULL
~862	NULL
CAT	NULL
~329	NULL
CAT	NULL
~45	NULL
CAT	NULL
u	NULL
o	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
of	NULL
the	NULL
PTHrP	NULL
promoter	NULL
deletion	NULL
mu-tants	NULL
.	NULL

A	NULL
2.7-kb	NULL
fragment	NULL
(	NULL
Hindill/Ase	NULL
1	NULL
)	NULL
of	NULL
the	NULL
down-	NULL
60	NULL
stream	NULL
PTHrP	NULL
promoter	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
Xba	NULL
I	NULL
site	NULL
of	NULL
CATMS54PA	NULL
.	NULL

PTHrP	NULL
deletion	NULL
constructs	NULL
were	NULL
generated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
are	NULL
named	NULL
for	NULL
the	NULL
5	NULL
'	NULL
end	NULL
point	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
exon	NULL
2	NULL
start	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transactivation	NULL
of	NULL
PTHrP-promoter	NULL
deletion	NULL
constructs	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
R	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
.	NULL

MLA	NULL
144	NULL
T	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
PTHrPCAT	NULL
deletion	NULL
mutants	NULL
(	NULL
8	NULL
ug	NULL
)	NULL
and	NULL
HTLV-I	NULL
Tax	NULL
(	NULL
BC3.9	NULL
Sph	NULL
)	NULL
20	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
or	NULL
HTLV-II	NULL
Tax	NULL
(	NULL
BC20.2	NULL
Sph	NULL
)	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
48	NULL
hours	NULL
before	NULL
harvest	NULL
and	NULL
CAT	NULL
<	NULL
assay	NULL
.	NULL

Total	NULL
amount	NULL
of	NULL
DNA	NULL
per	NULL
transfection	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
addition	NULL
of	NULL
BC12	NULL
(	NULL
vector	NULL
alone	NULL
without	NULL
Tax	NULL
cDNA	NULL
)	NULL
.	NULL

0-4	NULL
Acetylated	NULL
and	NULL
nonacetylated	NULL
HTLV-I	NULL
!	NULL

TAX	NULL
=	NULL
o	NULL
$	NULL
=	NULL
forms	NULL
of	NULL
chloramphenicol	NULL
were	NULL
quantitated	NULL
by	NULL
liquid	NULL
scintillation	NULL
I	NULL
counting	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
40	NULL
YoACETYLATION	NULL
as	NULL
percentage	NULL
of	NULL
acetylation	NULL
.	NULL

v§	NULL
G	NULL
Data	NULL
are	NULL
from	NULL
a	NULL
representative	NULL
5	NULL
experiment	NULL
independently	NULL
per-	NULL
é	NULL
formed	NULL
18	NULL
times	NULL
.	NULL

5b	NULL
activity	NULL
was	NULL
observed	NULL
with	NULL
HTLV-I	NULL
Tax	NULL
cotransfection	NULL
.	NULL

Cotransfection	NULL
of	NULL
all	NULL
the	NULL
PTHrPCAT	NULL
deletion	NULL
mutants	NULL
and	NULL
HTLV-I	NULL
Tax	NULL
into	NULL
729	NULL
B	NULL
cells	NULL
did	NULL
not	NULL
show	NULL
an	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
by	NULL
Tax	NULL
,	NULL
showing	NULL
that	NULL
progressive	NULL
5	NULL
'	NULL
deletion	NULL
of	NULL
the	NULL
promoter	NULL
can	NULL
not	NULL
overcome	NULL
the	NULL
apparent	NULL
requirement	NULL
for	NULL
a	NULL
cell-specific	NULL
factor	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
indicates	NULL
that	NULL
none	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
express	NULL
PTHrP	NULL
in	NULL
the	NULL
basal	NULL
or	NULL
phorbol	NULL
ester-treated	NULL
state	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
MLA	NULL
144	NULL
HTLV-II	NULL
TAX	NULL
_	NULL
;	NULL
-	NULL
_-	NULL
+	NULL
gibbon	NULL
T	NULL
cells	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressed	NULL
PTHrP	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
Tax	NULL
.	NULL

In	NULL
729	NULL
pH6neo	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
B	NULL
cells	NULL
productively	NULL
infected	NULL
with	NULL
the	NULL
HTLV-II	NULL
virus	NULL
``	NULL
and	NULL
in	NULL
which	NULL
HTLV-II	NULL
Tax	NULL
is	NULL
constitutively	NULL
produced	NULL
,	NULL
no	NULL
PTHrP	NULL
mRNA	NULL
was	NULL
detected	NULL
;	NULL
Tax	NULL
also	NULL
failed	NULL
to	NULL
transactivate	NULL
the	NULL
PTHrP	NULL
promoter	NULL
in	NULL
transient	NULL
cotransfection	NULL
assays	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
Tax-mediated	NULL
activation	NULL
of	NULL
PTHrP	NULL
gene	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
T	NULL
lym-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1020	NULL
EJIMA	NULL
ET	NULL
AL	NULL
PTHrP	NULL
IL2Ra	NULL
LTR	NULL
86.1	NULL
100	NULL
100	NULL
100	NULL
80-	NULL
80-	NULL
80	NULL
z	NULL
9	NULL
s0-	NULL
96.9	NULL
60-	NULL
60	NULL
P	NULL
3	NULL
t	NULL
a	NULL
-I	NULL
40.5	NULL
ty	NULL
9	NULL
-	NULL
40o-	NULL
40-	NULL
40-a	NULL
-	NULL
-_	NULL
20-	NULL
20-	NULL
20-i	NULL
4.4	NULL
1.6	NULL
~	NULL
1.9	NULL
a	NULL
-	NULL
'	NULL
L	NULL
a	NULL
L	NULL
1	NULL
1	NULL
0	NULL
CONT	NULL
.	NULL

TAX	NULL
TAXA984	NULL
NFKB	NULL
CONT	NULL
.	NULL

TAX	NULL
_	NULL
TAXA984	NULL
NFkB	NULL
CONT	NULL
.	NULL

TAX	NULL
TAXA984	NULL
NFkB	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
Transactivation	NULL
of	NULL
-2673PTHrPCAT	NULL
,	NULL
112R	NULL
&	NULL
CAT	NULL
,	NULL
and	NULL
HTLV-I	NULL
LTRCAT	NULL
by	NULL
HTLV-I	NULL
Tax/Rex	NULL
,	NULL
Tax	NULL
A984	NULL
,	NULL
and	NULL
NFkB	NULL
.	NULL

MLA	NULL
T	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
the	NULL
same	NULL
indicated	NULL
DNA	NULL
as	NULL
those	NULL
in	NULL
Fig	NULL
1B	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

Values	NULL
above	NULL
the	NULL
bars	NULL
are	NULL
the	NULL
fold	NULL
induction	NULL
.	NULL

phocytes	NULL
and	NULL
may	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
T-lymphoid-specific	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Patients	NULL
with	NULL
humoral	NULL
hypercalcemia	NULL
of	NULL
malignancy	NULL
exhibit	NULL
signs	NULL
of	NULL
abnormal	NULL
calcium	NULL
metabolism	NULL
:	NULL
increased	NULL
renal	NULL
40	NULL
%	NULL
ACETYLATION	NULL
Fig	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
and	NULL
Tax	NULL
A984	NULL
mutant	NULL
on	NULL
PTHrP	NULL
deletion	NULL
constructs	NULL
.	NULL

MLA	NULL
T	NULL
cells	NULL
were	NULL
electroporated	NULL
as	NULL
described	NULL
.	NULL

Data	NULL
are	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
performed	NULL
independently	NULL
three	NULL
times	NULL
.	NULL

Values	NULL
above	NULL
the	NULL
bars	NULL
are	NULL
the	NULL
fold	NULL
induction	NULL
.	NULL

tubular	NULL
resorption	NULL
of	NULL
calcium	NULL
,	NULL
elevated	NULL
nephrogenous	NULL
cyclic	NULL
AMP	NULL
,	NULL
and	NULL
increased	NULL
bone	NULL
resorption	NULL
.	NULL
``	NULL

Although	NULL
IL-1	NULL
,	NULL
a	NULL
cy-tokine	NULL
,	NULL
was	NULL
initially	NULL
proposed	NULL
to	NULL
be	NULL
a	NULL
causative	NULL
factor	NULL
of	NULL
the	NULL
hypercalcemia	NULL
because	NULL
of	NULL
its	NULL
osteoclast-activating	NULL
properties	NULL
,	NULL
the	NULL
metabolic	NULL
derangements	NULL
that	NULL
resemble	NULL
hyperparathy-roidism	NULL
are	NULL
not	NULL
explained	NULL
by	NULL
IL-1	NULL
.	NULL

Furthermore	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
8	NULL
(	NULL
TNF-8	NULL
)	NULL
,	NULL
a	NULL
cytokine	NULL
with	NULL
bone	NULL
resorbing	NULL
activity	NULL
has	NULL
also	NULL
been	NULL
postulated	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
hypercalcemia	NULL
of	NULL
ATL	NULL
.	NULL

*	NULL
However	NULL
,	NULL
not	NULL
all	NULL
tumor	NULL
cells	NULL
of	NULL
ATL	NULL
produce	NULL
TNF-8	NULL
and	NULL
TNF-8	NULL
levels	NULL
may	NULL
be	NULL
normal	NULL
in	NULL
patients	NULL
with	NULL
acute	NULL
ATL	NULL
.	NULL

Fresh	NULL
leukemic	NULL
cells	NULL
isolated	NULL
from	NULL
patients	NULL
%	NULL
ACETYLATION	NULL
20	NULL
10	NULL
4	NULL
CONT	NULL
.	NULL

0	NULL
0.5	NULL
1.0	NULL
20	NULL
4.0	NULL
2.0	NULL
c-JUN	NULL
L__________	NULL
]	NULL
(	NULL
ng	NULL
)	NULL
TAX	NULL
41g	NULL
Fig	NULL
4	NULL
.	NULL

|	NULL
Transactivation	NULL
of	NULL
-2673PTHrPCAT	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
and	NULL
c-jun	NULL
cotransfection	NULL
.	NULL

MLA	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
-2673	NULL
PTHrPCAT	NULL
(	NULL
8	NULL
ug	NULL
)	NULL
,	NULL
HTLV-I	NULL
Tax	NULL
(	NULL
4	NULL
2g	NULL
)	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
c-jun	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PTHrP	NULL
PROMOTER	NULL
TRANSACTIVATION	NULL
80	NULL
40	NULL
YoACETYLATION	NULL
MLA	NULL
729	NULL
RAT-1	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
Transactivation	NULL
of	NULL
-2673PTHrPCAT	NULL
and	NULL
HTLV-I	NULL
LTRCAT	NULL
by	NULL
c-jun	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

MLA	NULL
T	NULL
cells	NULL
,	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
Rat	NULL
1	NULL
fibroblasts	NULL
were	NULL
electroporated	NULL
with	NULL
-2673PTHrPCAT	NULL
(	NULL
8	NULL
ug	NULL
)	NULL
,	NULL
c-jun	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
,	NULL
and	NULL
LTR-1CAT	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
.	NULL

Data	NULL
are	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

with	NULL
ATL	NULL
constitutively	NULL
produce	NULL
transforming	NULL
growth	NULL
factor	NULL
B1	NULL
mRNA	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
the	NULL
TGF-81	NULL
promoter	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
transactivated	NULL
by	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
protein	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
exogenous	NULL
TGF-81	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
rat	NULL
PTHrP	NULL
in	NULL
keratinocytes	NULL
.	NULL
``	NULL

Significant	NULL
expression	NULL
of	NULL
the	NULL
PTHrP	NULL
gene	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
all	NULL
patients	NULL
with	NULL
ATL	NULL
;	NULL
therefore	NULL
,	NULL
PTHrP	NULL
is	NULL
a	NULL
leading	NULL
candidate	NULL
hypercalcemic	NULL
factor	NULL
in	NULL
ATL	NULL
.	NULL

Recently	NULL
,	NULL
HTLV-I	NULL
Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
transactivate	NULL
PTHrP	NULL
.	NULL
``	NULL

These	NULL
studies	NULL
were	NULL
performed	NULL
to	NULL
elucidate	NULL
the	NULL
mechanisms	NULL
whereby	NULL
Tax	NULL
might	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
pathogenesis	NULL
of	NULL
hypercalcemia	NULL
in	NULL
ATL	NULL
,	NULL
by	NULL
direct	NULL
stimulation	NULL
of	NULL
PTHrP	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Both	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
proteins	NULL
transactivate	NULL
the	NULL
downstream	NULL
PTHrP	NULL
promoter	NULL
despite	NULL
the	NULL
absence	NULL
of	NULL
NFB	NULL
and	NULL
classical	NULL
CRE	NULL
motifs	NULL
.	NULL

The	NULL
longest	NULL
construct	NULL
,	NULL
-2673PTHrPCAT	NULL
,	NULL
showed	NULL
the	NULL
greatest	NULL
induction	NULL
by	NULL
the	NULL
Tax	NULL
proteins	NULL
.	NULL

However	NULL
,	NULL
this	NULL
function	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
Tax	NULL
proteins	NULL
was	NULL
found	NULL
to	NULL
be	NULL
cell	NULL
type-specific	NULL
because	NULL
it	NULL
was	NULL
only	NULL
present	NULL
in	NULL
transfected	NULL
T	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
B	NULL
cells	NULL
or	NULL
fibroblasts	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
was	NULL
transactivated	NULL
by	NULL
Tax	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
tested	NULL
.	NULL

Furthermore	NULL
,	NULL
Northern	NULL
analysis	NULL
indicates	NULL
that	NULL
only	NULL
productively	NULL
HTLV-I~-infected	NULL
T	NULL
cells	NULL
express	NULL
PTHrP	NULL
mRNA	NULL
and	NULL
that	NULL
even	NULL
when	NULL
B	NULL
cells	NULL
are	NULL
productively	NULL
infected	NULL
with	NULL
HTLV-II	NULL
(	NULL
729	NULL
pH6neo	NULL
)	NULL
,	NULL
the	NULL
cells	NULL
still	NULL
fail	NULL
to	NULL
express	NULL
PTHrP	NULL
mRNA	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
cell-specific	NULL
effects	NULL
on	NULL
PTHrP	NULL
may	NULL
also	NULL
relate	NULL
to	NULL
T-cell-specific	NULL
transformation	NULL
.	NULL

This	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-	NULL
1021	NULL
CSF	NULL
)	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
also	NULL
cell-type	NULL
specific	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
in	NULL
transgenic	NULL
mice	NULL
'	NULL
``	NULL
and	NULL
differs	NULL
from	NULL
Tax	NULL
effects	NULL
on	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

The	NULL
proto-oncogene	NULL
c-jun	NULL
significantly	NULL
transactivated	NULL
the	NULL
PTHrP	NULL
promoter	NULL
with	NULL
little	NULL
further	NULL
augmentation	NULL
by	NULL
Tax	NULL
.	NULL

Both	NULL
Tax	NULL
and	NULL
c-jun	NULL
transactivated	NULL
PTHrP	NULL
efficiently	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Tax	NULL
transactivation	NULL
may	NULL
be	NULL
working	NULL
via	NULL
c-jun	NULL
induction	NULL
.	NULL

Studies	NULL
with	NULL
HTLV-I	NULL
LTR	NULL
show	NULL
that	NULL
induction	NULL
by	NULL
v-jun	NULL
can	NULL
occur	NULL
through	NULL
the	NULL
Tax	NULL
responsive	NULL
21-bp	NULL
repeats	NULL
.	NULL

However	NULL
,	NULL
whereas	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
Jun/AP-1	NULL
can	NULL
activate	NULL
the	NULL
LTR	NULL
,	NULL
jun	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
LTR	NULL
transactivation	NULL
by	NULL
Tax	NULL
.	NULL
``	NULL

The	NULL
carboxy	NULL
terminal	NULL
domain	NULL
of	NULL
the	NULL
Tax	NULL
protein	NULL
but	NULL
not	NULL
NF	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
PTHrP	NULL
transactivation	NULL
.	NULL

Tax	NULL
A984	NULL
abrogates	NULL
PTHrP-promoter-induction	NULL
and	NULL
,	NULL
unlike	NULL
the	NULL
1L2R	NULL
«	NULL
promoter	NULL
,	NULL
exogenously	NULL
provided	NULL
p65/p50	NULL
NFxB	NULL
fails	NULL
to	NULL
rescue	NULL
PTHrP	NULL
gene	NULL
expression	NULL
.	NULL

Therefore	NULL
,	NULL
Tax	NULL
transactivation	NULL
of	NULL
PTHrP	NULL
involves	NULL
multiple	NULL
protein-protein	NULL
interactions	NULL
with	NULL
the	NULL
acidic	NULL
carboxy	NULL
terminal	NULL
region	NULL
,	NULL
but	NULL
these	NULL
interactions	NULL
probably	NULL
differ	NULL
from	NULL
those	NULL
involved	NULL
in	NULL
transactivation	NULL
of	NULL
the	NULL
1L-2Ra	NULL
promoter	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
defect	NULL
in	NULL
Tax	NULL
A984	NULL
,	NULL
although	NULL
related	NULL
to	NULL
failure	NULL
of	NULL
NFxB	NULL
induction	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
IL2Ra	NULL
promoter	NULL
,	NULL
probably	NULL
involves	NULL
another	NULL
factor	NULL
in	NULL
the	NULL
case	NULL
of	NULL
PTHrP	NULL
.	NULL

The	NULL
PTHrP	NULL
promoter	NULL
contains	NULL
a	NULL
``	NULL
CGCCCCCGC	NULL
``	NULL
motif	NULL
that	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
an	NULL
EGR-1	NULL
binding	NULL
site	NULL
.	NULL
``	NULL

''	NULL
The	NULL
EGR-1	NULL
gene	NULL
encodes	NULL
a	NULL
zinc	NULL
finger	NULL
containing	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
numerous	NULL
cell	NULL
types	NULL
.	NULL
``	NULL

EGR-1	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
HTLV-I	NULL
80	NULL
60	NULL
Z	NULL
9	NULL
6	NULL
3	NULL
>	NULL
40	NULL
{	NULL
E-Lu	NULL
0	NULL
<	NULL
&	NULL
20	NULL
0	NULL
O64	NULL
C404	NULL
)	NULL
P	NULL
8	NULL
_	NULL
_	NULL
$	NULL
£	NULL
-	NULL
$	NULL
&	NULL
|	NULL
e	NULL
J	NULL
-	NULL
L_	NULL
]	NULL
MLA	NULL
729	NULL
RATA	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Transactivation	NULL
of	NULL
-2673PTHrPCAT	NULL
and	NULL
HTLV-I	NULL
LTRCAT	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

MLA	NULL
T	NULL
cells	NULL
,	NULL
729	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
Rat	NULL
1	NULL
fibroblasts	NULL
were	NULL
transfected	NULL
with	NULL
-2673PTHrPCAT	NULL
(	NULL
8	NULL
ug	NULL
)	NULL
,	NULL
LTR-1CAT	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
,	NULL
and	NULL
HTLV-1	NULL
Tax	NULL
(	NULL
4	NULL
ug	NULL
)	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

EJIMA	NULL
ET	NULL
AL	NULL
1022	NULL
<	NULL
a	NULL
.	NULL

<	NULL
r	NULL
[	NULL
eN	NULL
0	NULL
lel	NULL
<	NULL
0	NULL
<	NULL
0	NULL
Eo	NULL
a	NULL
5	NULL
2	NULL
2	NULL
a.	NULL
a_	NULL
+	NULL
p-	NULL
©	NULL
w	NULL
Eo	NULL
Ey	NULL
x	NULL
f	NULL
+	NULL
*	NULL
%	NULL
+	NULL
£	NULL
%	NULL
*	NULL
F	NULL
l	NULL
a	NULL
a	NULL
2	NULL
&	NULL
E	NULL
£	NULL
2	NULL
<	NULL
z	NULL
g	NULL
g	NULL
Kb	NULL
p33	NULL
a	NULL
<	NULL
m_	NULL
C_	NULL
C	NULL
m__	NULL
PTHrP	NULL
2.37	NULL
--	NULL
-	NULL
(	NULL
yactin	NULL
F	NULL
and	NULL
HTLV-II	NULL
transformed	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
aberrant	NULL
expression	NULL
of	NULL
EGR-1	NULL
in	NULL
response	NULL
to	NULL
Tax	NULL
might	NULL
bypass	NULL
the	NULL
signals	NULL
that	NULL
normally	NULL
induce	NULL
T-cell	NULL
proliferation	NULL
and	NULL
contribute	NULL
to	NULL
T-cell	NULL
transformation	NULL
.	NULL

**	NULL
The	NULL
product	NULL
of	NULL
the	NULL
Wilm	NULL
's	NULL
tumor	NULL
locus	NULL
is	NULL
also	NULL
a	NULL
zinc	NULL
finger	NULL
containing	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
EBS	NULL
(	NULL
EGR	NULL
binding	NULL
site	NULL
)	NULL
.	NULL
``	NULL

Mutations	NULL
of	NULL
the	NULL
Wilm	NULL
's	NULL
tumor	NULL
locus	NULL
protein	NULL
may	NULL
result	NULL
in	NULL
its	NULL
deficient	NULL
binding	NULL
to	NULL
the	NULL
EBS	NULL
and	NULL
lead	NULL
to	NULL
deregulated	NULL
expression	NULL
of	NULL
genes	NULL
containing	NULL
this	NULL
element	NULL
.	NULL

Numerous	NULL
potential	NULL
Ets-1	NULL
binding	NULL
sites	NULL
,	NULL
characterized	NULL
by	NULL
the	NULL
GGAA/T	NULL
motif	NULL
,	NULL
are	NULL
also	NULL
present	NULL
on	NULL
the	NULL
downstream	NULL
PTHrP	NULL
promoter	NULL
.	NULL

Ets-1	NULL
is	NULL
a	NULL
nuclear	NULL
chromatin-associated	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL
``	NULL

An	NULL
Ets-responsive	NULL
sequence	NULL
(	NULL
ERR-1	NULL
)	NULL
containing	NULL
2	NULL
DNA	NULL
binding	NULL
sites	NULL
,	NULL
ERE-A	NULL
and	NULL
ERE-B	NULL
,	NULL
on	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
part	NULL
of	NULL
the	NULL
transcriptional	NULL
response	NULL
to	NULL
Tax	NULL
1.5	NULL
``	NULL
The	NULL
role	NULL
of	NULL
the	NULL
Ets-1	NULL
protein	NULL
and	NULL
the	NULL
EBS	NULL
as	NULL
pertains	NULL
to	NULL
PTHrP	NULL
gene	NULL
expression	NULL
needs	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
Ets-1	NULL
contributes	NULL
to	NULL
the	NULL
cell	NULL
specificity	NULL
which	NULL
we	NULL
observed	NULL
.	NULL

Infection	NULL
of	NULL
permissive	NULL
host	NULL
cells	NULL
with	NULL
HTLV-I	NULL
appears	NULL
to	NULL
induce	NULL
transformation	NULL
by	NULL
a	NULL
novel	NULL
mechanism	NULL
because	NULL
Tax	NULL
does	NULL
not	NULL
encode	NULL
a	NULL
known	NULL
oncogene	NULL
product	NULL
.	NULL

*	NULL
Tax	NULL
induces	NULL
neoplastic	NULL
transformation	NULL
of	NULL
rat	NULL
embryo	NULL
fibroblasts	NULL
in	NULL
cooperation	NULL
with	NULL
H-Ras	NULL
.	NULL
``	NULL

'	NULL
Furthermore	NULL
,	NULL
mutant	NULL
Tax	NULL
proteins	NULL
,	NULL
which	NULL
loose	NULL
the	NULL
ability	NULL
to	NULL
induce	NULL
NFx	NULL
«	NULL
B/rel	NULL
but	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
transactivate	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
and	NULL
c-fos	NULL
promoter	NULL
,	NULL
mediate	NULL
transformation	NULL
of	NULL
rat	NULL
2	NULL
fibroblasts	NULL
.	NULL
``	NULL

Because	NULL
Tax	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
many	NULL
cellular	NULL
genes	NULL
,	NULL
'*	NULL
>	NULL
this	NULL
may	NULL
contribute	NULL
to	NULL
its	NULL
transforming	NULL
ability	NULL
and	NULL
to	NULL
the	NULL
diverse	NULL
clinical	NULL
Fig	NULL
7	NULL
.	NULL

-	NULL
Northern	NULL
Blot	NULL
analysis	NULL
of	NULL
RNA	NULL
.	NULL

Control	NULL
or	NULL
TPA	NULL
(	NULL
50	NULL
nmol/L	NULL
)	NULL
treated	NULL
(	NULL
4	NULL
hours	NULL
)	NULL
cytoplasmic	NULL
RNA	NULL
(	NULL
60	NULL
ug	NULL
)	NULL
was	NULL
electrophoresed	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
transferred	NULL
to	NULL
a	NULL
membrane	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
°2P-labeled	NULL
PTHrP	NULL
cDNA	NULL
and	NULL
y-actin	NULL
cDNA	NULL
.	NULL

The	NULL
1.6-	NULL
and	NULL
2.1	NULL
-kb	NULL
human	NULL
PTHrP	NULL
mRNA	NULL
bands	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
2.2	NULL
kb	NULL
y-actin	NULL
mRNA	NULL
transcript	NULL
(	NULL
used	NULL
as	NULL
a	NULL
constitutive	NULL
probe	NULL
)	NULL
is	NULL
indicated	NULL
.	NULL

manifestations	NULL
observed	NULL
following	NULL
retroviral	NULL
infection	NULL
.	NULL

The	NULL
cell-specific	NULL
interaction	NULL
of	NULL
the	NULL
PTHrP	NULL
promoter	NULL
with	NULL
the	NULL
Tax	NULL
proteins	NULL
will	NULL
provide	NULL
insight	NULL
into	NULL
the	NULL
mechanisms	NULL
of	NULL
hypercalcemia	NULL
in	NULL
ATL	NULL
,	NULL
and	NULL
possibly	NULL
allow	NULL
for	NULL
the	NULL
design	NULL
of	NULL
targeted	NULL
drug	NULL
therapy	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
V.	NULL
Baichwal	NULL
for	NULL
the	NULL
c-jun	NULL
expression	NULL
plasmid	NULL
,	NULL
D.	NULL
Goltzman	NULL
and	NULL
G.	NULL
Hendy	NULL
for	NULL
clone	NULL
SH1	NULL
,	NULL
and	NULL
C.	NULL
Ramirez	NULL
for	NULL
secretarial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Kalyanaraman	NULL
VS	NULL
,	NULL
Sarngadharan	NULL
MG	NULL
,	NULL
Robert-Guroff	NULL
M	NULL
,	NULL
Miyoshi	NULL
I	NULL
,	NULL
Blayney	NULL
D	NULL
,	NULL
Golde	NULL
D	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
A	NULL
new	NULL
subtype	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-II	NULL
)	NULL
associated	NULL
with	NULL
a	NULL
T-cell	NULL
variant	NULL
of	NULL
hairy	NULL
cell	NULL
leukemia	NULL
.	NULL

Science	NULL
218:571	NULL
,	NULL
1982	NULL
2	NULL
.	NULL

Rosenblatt	NULL
JD	NULL
,	NULL
Golde	NULL
DW	NULL
,	NULL
Wachsman	NULL
W	NULL
,	NULL
Giorgi	NULL
JV	NULL
,	NULL
Andrew	NULL
J	NULL
,	NULL
Schmidt	NULL
GM	NULL
,	NULL
Quan	NULL
S	NULL
,	NULL
Gasson	NULL
JC	NULL
,	NULL
Chen	NULL
ISY	NULL
:	NULL
A	NULL
second	NULL
isolate	NULL
of	NULL
HTLV-II	NULL
associated	NULL
with	NULL
atypical	NULL
hairy-cell	NULL
leukemia	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
315:372	NULL
,	NULL
1986	NULL
3	NULL
.	NULL

Rosenblatt	NULL
JD	NULL
,	NULL
Giorgi	NULL
JV	NULL
,	NULL
Golde	NULL
DW	NULL
,	NULL
Ezra	NULL
JB	NULL
,	NULL
Wu	NULL
A	NULL
,	NULL
Winberg	NULL
CD	NULL
,	NULL
Glaspy	NULL
J	NULL
,	NULL
Wachsman	NULL
W	NULL
,	NULL
Chen	NULL
ISY	NULL
:	NULL
Integrated	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
II	NULL
genome	NULL
in	NULL
CD8+	NULL
T	NULL
cells	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
``	NULL
atyp-ical	NULL
``	NULL
hairy	NULL
cell	NULL
leukemia	NULL
:	NULL
Evidence	NULL
for	NULL
distinct	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lympho-proliferative	NULL
disorders	NULL
.	NULL

Blood	NULL
71:363	NULL
,	NULL
1988	NULL
4	NULL
.	NULL

Yoshida	NULL
M	NULL
,	NULL
Miyoshi	NULL
I	NULL
,	NULL
Hinuma	NULL
Y	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retrovirus	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
79:2031	NULL
,	NULL
1982	NULL
5	NULL
.	NULL

Strewler	NULL
GJ	NULL
,	NULL
Stern	NULL
PH	NULL
,	NULL
Jacobs	NULL
JW	NULL
,	NULL
Eveloft	NULL
J	NULL
,	NULL
Klein	NULL
RF	NULL
,	NULL
Leung	NULL
SC	NULL
,	NULL
Rosenblatt	NULL
M	NULL
,	NULL
Nissenson	NULL
RA	NULL
:	NULL
Parathyroid	NULL
hormone-like	NULL
protein	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PROMOTER	NULL
TRANSACTIVATION	NULL
from	NULL
human	NULL
renal	NULL
carcinoma	NULL
cells	NULL
:	NULL
Structural	NULL
and	NULL
functional	NULL
ho-mology	NULL
with	NULL
parathyroid	NULL
hormone	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
80:1803	NULL
,	NULL
1987	NULL
6	NULL
.	NULL

Mangin	NULL
M	NULL
,	NULL
Webb	NULL
AC	NULL
,	NULL
Dreger	NULL
BE	NULL
,	NULL
Posillico	NULL
JT	NULL
,	NULL
Ikeda	NULL
K	NULL
,	NULL
Weir	NULL
EC	NULL
,	NULL
Stewart	NULL
AF	NULL
,	NULL
Bander	NULL
NH	NULL
,	NULL
Milstone	NULL
L	NULL
,	NULL
Barton	NULL
DE	NULL
,	NULL
Francke	NULL
U	NULL
,	NULL
Broadus	NULL
AE	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
cDNA	NULL
encoding	NULL
a	NULL
parathyroid	NULL
hormone-like	NULL
peptide	NULL
from	NULL
a	NULL
human	NULL
tumor	NULL
associated	NULL
with	NULL
humoral	NULL
hypercalcemia	NULL
of	NULL
malignancy	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:597	NULL
,	NULL
1988	NULL
7	NULL
.	NULL

Goltzman	NULL
D	NULL
,	NULL
Yasuda	NULL
T	NULL
,	NULL
Banville	NULL
D	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
human	NULL
parathyroid	NULL
hormone-like	NULL
peptide	NULL
gene	NULL
:	NULL
Functional	NULL
and	NULL
evolutionary	NULL
aspects	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:7720	NULL
,	NULL
1989	NULL
8	NULL
.	NULL

Suva	NULL
LJ	NULL
,	NULL
Winslow	NULL
GA	NULL
,	NULL
Wettenhall	NULL
REH	NULL
,	NULL
Hammonds	NULL
RG	NULL
,	NULL
Moseley	NULL
JM	NULL
,	NULL
Diefenback-Jagger	NULL
H	NULL
,	NULL
Rodda	NULL
CP	NULL
,	NULL
Kemp	NULL
BE	NULL
,	NULL
Rodriguez	NULL
H	NULL
,	NULL
Chen	NULL
EY	NULL
,	NULL
Hudson	NULL
PJ	NULL
,	NULL
Martin	NULL
TJ	NULL
,	NULL
Wood	NULL
WI	NULL
:	NULL
A	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
implicated	NULL
in	NULL
malignant	NULL
hypercalcemia	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
.	NULL

Science	NULL
237:893	NULL
,	NULL
1987	NULL
9	NULL
.	NULL

Mangin	NULL
M	NULL
,	NULL
Ikeda	NULL
K	NULL
,	NULL
Dreyer	NULL
BE	NULL
,	NULL
Broadus	NULL
AE	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
parathyroid	NULL
hormone-like	NULL
peptide	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:2408	NULL
,	NULL
1989	NULL
10	NULL
.	NULL

Watanabe	NULL
T	NULL
,	NULL
Yamaguchi	NULL
K	NULL
,	NULL
Takasuki	NULL
K	NULL
,	NULL
Osame	NULL
M	NULL
,	NULL
Yoshida	NULL
M.	NULL
Constitutive	NULL
expression	NULL
of	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
gene	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-I	NULL
)	NULL
carriers	NULL
and	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
patients	NULL
that	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1972:759	NULL
,	NULL
1990	NULL
11	NULL
.	NULL

Motokura	NULL
T	NULL
,	NULL
Fukumoto	NULL
S	NULL
,	NULL
Matsumoto	NULL
T	NULL
,	NULL
Takahashi	NULL
S	NULL
,	NULL
Fujita	NULL
A	NULL
,	NULL
Yamashita	NULL
TR	NULL
,	NULL
Igarashi	NULL
T	NULL
,	NULL
Ogata	NULL
E	NULL
:	NULL
Parathyroid	NULL
hormone-related	NULL
protein	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia-lymphoma	NULL
.	NULL

Ann	NULL
Intern	NULL
Med	NULL
111	NULL
:	NULL
484	NULL
,	NULL
1989	NULL
12	NULL
.	NULL

Smith	NULL
MR	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Molecular	NULL
biology	NULL
of	NULL
the	NULL
type	NULL
1	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
and	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
87:761	NULL
,	NULL
1991	NULL
13	NULL
.	NULL

Black	NULL
AC	NULL
,	NULL
Ruland	NULL
CT	NULL
,	NULL
Yip	NULL
MT	NULL
,	NULL
Luo	NULL
J	NULL
,	NULL
Tran	NULL
B	NULL
,	NULL
Kalsi	NULL
A	NULL
,	NULL
Quan	NULL
E	NULL
,	NULL
Aboud	NULL
M	NULL
,	NULL
Chen	NULL
Sy	NULL
,	NULL
Rosenblatt	NULL
JD	NULL
:	NULL
Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
II	NULL
rex	NULL
binding	NULL
and	NULL
activity	NULL
requires	NULL
an	NULL
intact	NULL
splice	NULL
donor	NULL
site	NULL
and	NULL
a	NULL
specific	NULL
RNA	NULL
secondary	NULL
structure	NULL
.	NULL

J	NULL
Virol	NULL
65:6645	NULL
,	NULL
1991	NULL
14	NULL
.	NULL

Sodroski	NULL
J	NULL
,	NULL
Rosen	NULL
C	NULL
,	NULL
Goh	NULL
WC	NULL
,	NULL
Haseltine	NULL
W	NULL
:	NULL
A	NULL
transcriptional	NULL
activator	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
x-lor	NULL
region	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228:1430	NULL
,	NULL
1985	NULL
15	NULL
.	NULL

Felber	NULL
BK	NULL
,	NULL
Paskalis	NULL
H	NULL
,	NULL
Kleinman-Ewing	NULL
C	NULL
,	NULL
Wong-Staal	NULL
F	NULL
,	NULL
Pavlakis	NULL
GN	NULL
:	NULL
The	NULL
pX	NULL
protein	NULL
of	NULL
HTLV-I	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
its	NULL
long	NULL
terminal	NULL
repeats	NULL
.	NULL

Science	NULL
229:675	NULL
,	NULL
1985	NULL
16	NULL
.	NULL

Green	NULL
JE	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Wagner	NULL
DK	NULL
,	NULL
Waldmann	NULL
TA	NULL
,	NULL
Jay	NULL
G	NULL
:	NULL
Transactivation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
in	NULL
transgenic	NULL
mice	NULL
carrying	NULL
the	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
tax	NULL
gene	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
9:4731	NULL
,	NULL
1989	NULL
17	NULL
.	NULL

Green	NULL
JE	NULL
:	NULL
Transactivation	NULL
of	NULL
nerve	NULL
growth	NULL
factor	NULL
in	NULL
transgenic	NULL
mice	NULL
containing	NULL
the	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
tax	NULL
gene	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:4634	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Joshi	NULL
JB	NULL
,	NULL
Dave	NULL
PGH	NULL
:	NULL
Transactivation	NULL
of	NULL
the	NULL
proenkephalin	NULL
gene	NULL
promoter	NULL
by	NULL
the	NULL
Tax	NULL
,	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:1006	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Ruben	NULL
S	NULL
,	NULL
Poteat	NULL
H	NULL
,	NULL
Tan	NULL
TH	NULL
,	NULL
Kawakami	NULL
K	NULL
,	NULL
Roeder	NULL
R	NULL
,	NULL
Haseltine	NULL
W	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
2:89	NULL
,	NULL
1988	NULL
20	NULL
.	NULL

Fujii	NULL
M	NULL
,	NULL
Sassone-Corsi	NULL
P	NULL
,	NULL
Verma	NULL
IM	NULL
:	NULL
c-fos	NULL
promoter	NULL
transactivation	NULL
by	NULL
the	NULL
tax	NULL
,	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:8526	NULL
,	NULL
1988	NULL
21	NULL
.	NULL

Alexander	NULL
C	NULL
,	NULL
Charnay	NULL
P	NULL
,	NULL
Verrier	NULL
B	NULL
:	NULL
Transactivation	NULL
of	NULL
Krox-20	NULL
and	NULL
Krox-24	NULL
promoters	NULL
by	NULL
the	NULL
HTLV-I	NULL
tax	NULL
protein	NULL
through	NULL
common	NULL
regulatory	NULL
elements	NULL
.	NULL

Oncogene	NULL
6:1851	NULL
,	NULL
1991	NULL
22	NULL
.	NULL

Nimer	NULL
SD	NULL
,	NULL
Gasson	NULL
JC	NULL
,	NULL
Hu	NULL
K	NULL
,	NULL
Smalberg	NULL
I	NULL
,	NULL
Williams	NULL
JL	NULL
,	NULL
Chen	NULL
ISY	NULL
,	NULL
Rosenblatt	NULL
JD	NULL
:	NULL
Activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
by	NULL
HTLV-I	NULL
and	NULL
-II	NULL
tax	NULL
proteins	NULL
.	NULL

Oncogene	NULL
4:671	NULL
,	NULL
1989	NULL
1023	NULL
23	NULL
.	NULL

Marriott	NULL
SJ	NULL
,	NULL
Lindholm	NULL
PF	NULL
,	NULL
Brown	NULL
KM	NULL
,	NULL
Gitlin	NULL
SD	NULL
,	NULL
Radonovich	NULL
MF	NULL
,	NULL
Brady	NULL
JN	NULL
:	NULL
A	NULL
36-kilodalton	NULL
cellular	NULL
transcription	NULL
factor	NULL
mediates	NULL
an	NULL
indirect	NULL
interaction	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia/lymphoma	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
,	NULL
with	NULL
a	NULL
responsive	NULL
element	NULL
in	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
36:4192	NULL
,	NULL
1990	NULL
24	NULL
.	NULL

Yoshimura	NULL
T	NULL
,	NULL
Fujisawa	NULL
JI	NULL
,	NULL
Yoshida	NULL
M	NULL
:	NULL
Multiple	NULL
cDNA	NULL
clones	NULL
encoding	NULL
nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
tax-dependent	NULL
enhancer	NULL
of	NULL
HTLV-I	NULL
:	NULL
All	NULL
contain	NULL
a	NULL
leucine	NULL
zipper	NULL
structure	NULL
and	NULL
basic	NULL
amino	NULL
acid	NULL
domain	NULL
.	NULL

EMBO	NULL
J	NULL
9:2537	NULL
,	NULL
1990	NULL
25	NULL
.	NULL

Nabel	NULL
G	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T-cells	NULL
.	NULL

Nature	NULL
326:711	NULL
,	NULL
1987	NULL
26	NULL
.	NULL

Smith	NULL
MR	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Identification	NULL
of	NULL
HTLV-I	NULL
tax	NULL
transactivator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1875	NULL
,	NULL
1990	NULL
27	NULL
.	NULL

Leung	NULL
K	NULL
,	NULL
Nabel	NULL
G	NULL
:	NULL
HTLV-I	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NFxB-like	NULL
factor	NULL
.	NULL

Nature	NULL
333:776	NULL
,	NULL
1988	NULL
28	NULL
.	NULL

Chen	NULL
ISY	NULL
,	NULL
Slamon	NULL
DJ	NULL
,	NULL
Rosenblatt	NULL
JD	NULL
,	NULL
Shah	NULL
NP	NULL
,	NULL
Quan	NULL
SG	NULL
,	NULL
Wachsman	NULL
W	NULL
:	NULL
The	NULL
x	NULL
gene	NULL
is	NULL
essential	NULL
for	NULL
HTLV	NULL
replication	NULL
.	NULL

Science	NULL
229:54	NULL
,	NULL
1985	NULL
29	NULL
.	NULL

Rosenblatt	NULL
JD	NULL
,	NULL
Cann	NULL
AJ	NULL
,	NULL
Slamon	NULL
DJ	NULL
,	NULL
Smalberg	NULL
IS	NULL
,	NULL
Shah	NULL
NP	NULL
,	NULL
Fujii	NULL
J	NULL
,	NULL
Wachsman	NULL
W	NULL
,	NULL
Chen	NULL
ISY	NULL
:	NULL
HTLV-II	NULL
transactivation	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
overlapping	NULL
tax/rex	NULL
nonstructural	NULL
genes	NULL
.	NULL

Science	NULL
240	NULL
:	NULL
916	NULL
,	NULL
1988	NULL
30	NULL
.	NULL

Ruben	NULL
SM	NULL
,	NULL
Perkins	NULL
A	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
HTLV-I	NULL
trans-activator	NULL
protein	NULL
tax	NULL
requires	NULL
an	NULL
additional	NULL
factor	NULL
present	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

New	NULL
Biol	NULL
1:275	NULL
,	NULL
1989	NULL
31	NULL
.	NULL

Ruben	NULL
SM	NULL
,	NULL
Dillon	NULL
Narayanan	NULL
R	NULL
,	NULL
Klement	NULL
JF	NULL
,	NULL
Chen	NULL
C-H	NULL
,	NULL
Rosen	NULL
D	NULL
:	NULL
Functional	NULL
characterization	NULL
of	NULL
the	NULL
NFxB	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
spliced	NULL
derivative	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12	NULL
:	NULL
444	NULL
,	NULL
1992	NULL
32	NULL
.	NULL

Greene	NULL
WC	NULL
,	NULL
Kronke	NULL
M	NULL
,	NULL
Leonard	NULL
WJ	NULL
,	NULL
Depper	NULL
JM	NULL
:	NULL
Deregulation	NULL
of	NULL
interleukin-2	NULL
receptor	NULL
gene	NULL
expression	NULL
in	NULL
HTLV-I-induced	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Science	NULL
228:1215	NULL
,	NULL
1985	NULL
33	NULL
.	NULL

Baichwal	NULL
VR	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
Control	NULL
of	NULL
c-Jun	NULL
activity	NULL
by	NULL
interaction	NULL
of	NULL
a	NULL
cell-specific	NULL
inhibitor	NULL
with	NULL
regulatory	NULL
domain	NULL
é	NULL
:	NULL
Difference	NULL
between	NULL
v-	NULL
and	NULL
c-jun	NULL
.	NULL

Cell	NULL
63:81	NULL
5	NULL
,	NULL
1990	NULL
34	NULL
.	NULL

Potter	NULL
H	NULL
,	NULL
Weir	NULL
L	NULL
,	NULL
Leder	NULL
P	NULL
:	NULL
Enhancer-dependent	NULL
expression	NULL
of	NULL
human	NULL
x	NULL
immunoglobulin	NULL
genes	NULL
introduced	NULL
into	NULL
mouse	NULL
pre-B	NULL
lymphocytes	NULL
by	NULL
electroporation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
81:7161	NULL
,	NULL
1984	NULL
35	NULL
.	NULL

Bradford	NULL
MM	NULL
:	NULL
A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quanti-fication	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein	NULL
dye	NULL
binding	NULL
.	NULL

Anal	NULL
Biochem	NULL
72:248	NULL
,	NULL
1976	NULL
36	NULL
.	NULL

Gorman	NULL
CM	NULL
,	NULL
Moffat	NULL
LF	NULL
,	NULL
Howard	NULL
BH	NULL
:	NULL
Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
2	NULL
:	NULL
1044	NULL
,	NULL
1982	NULL
37	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extrac-tion	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
38	NULL
.	NULL

Thomas	NULL
PS	NULL
:	NULL
Hybridization	NULL
of	NULL
denatured	NULL
RNA	NULL
and	NULL
small	NULL
DNA	NULL
fragments	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77	NULL
:	NULL
5201	NULL
,	NULL
1980	NULL
39	NULL
.	NULL

Sakamoto	NULL
KM	NULL
,	NULL
Nimer	NULL
SD	NULL
,	NULL
Rosenblatt	NULL
JD	NULL
,	NULL
Gasson	NULL
JC	NULL
:	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
Tax	NULL
activate	NULL
the	NULL
human	NULL
EGR-1	NULL
promoter	NULL
through	NULL
different	NULL
cis-acting	NULL
sequences	NULL
.	NULL

Oncogene	NULL
7:2125	NULL
,	NULL
1992	NULL
40	NULL
.	NULL

Hooper	NULL
WC	NULL
,	NULL
Rudolph	NULL
DL	NULL
,	NULL
Lairmore	NULL
MD	NULL
,	NULL
Lal	NULL
RB	NULL
:	NULL
Constitutive	NULL
expression	NULL
of	NULL
c-jun	NULL
and	NULL
jun-B	NULL
in	NULL
cell	NULL
lines	NULL
infected	NULL
with	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
types	NULL
I	NULL
and	NULL
II	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
181:976	NULL
,	NULL
1991	NULL
41	NULL
.	NULL

Broadus	NULL
AE	NULL
,	NULL
Mangin	NULL
M	NULL
,	NULL
Ikeda	NULL
K	NULL
,	NULL
Insogna	NULL
KL	NULL
,	NULL
Weir	NULL
EC	NULL
,	NULL
Burtis	NULL
WJ	NULL
,	NULL
Stewart	NULL
AF	NULL
:	NULL
Humoral	NULL
hypercalcemia	NULL
of	NULL
cancer	NULL
:	NULL
Identification	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1024	NULL
of	NULL
a	NULL
novel	NULL
parathyroid	NULL
hormone-like	NULL
peptide	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
319:556	NULL
,	NULL
1988	NULL
42	NULL
.	NULL

Ishibashi	NULL
K	NULL
,	NULL
Ishitsuka	NULL
K	NULL
,	NULL
Chuman	NULL
Y	NULL
,	NULL
Otsuka	NULL
M	NULL
,	NULL
Kuwazuru	NULL
Y	NULL
,	NULL
Iwahashi	NULL
M	NULL
,	NULL
Utsunomiya	NULL
A	NULL
,	NULL
Hanada	NULL
S	NULL
$	NULL
,	NULL
Sakurami	NULL
T	NULL
,	NULL
Arima	NULL
T	NULL
:	NULL
Tumor	NULL
necrosis	NULL
factor-8	NULL
in	NULL
the	NULL
serum	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
with	NULL
hypercalcemia	NULL
.	NULL

Blood	NULL
77:2451	NULL
,	NULL
1991	NULL
43	NULL
.	NULL

Kim	NULL
SJ	NULL
,	NULL
Kehrl	NULL
JH	NULL
,	NULL
Burton	NULL
J	NULL
,	NULL
Tendler	NULL
CL	NULL
,	NULL
Jeang	NULL
KT	NULL
,	NULL
Daniel-pour	NULL
D	NULL
,	NULL
Thevenin	NULL
C	NULL
,	NULL
Kim	NULL
KY	NULL
,	NULL
Sporn	NULL
MB	NULL
,	NULL
Roberts	NULL
ANB	NULL
:	NULL
Transactivation	NULL
of	NULL
the	NULL
transforming	NULL
growth	NULL
factor	NULL
81	NULL
(	NULL
TGF-81	NULL
)	NULL
gene	NULL
by	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
tax	NULL
:	NULL
A	NULL
potential	NULL
mechanism	NULL
for	NULL
the	NULL
increased	NULL
production	NULL
of	NULL
TGF-81	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:121	NULL
,	NULL
1990	NULL
44	NULL
.	NULL

Allinson	NULL
ET	NULL
,	NULL
Drucker	NULL
DJ	NULL
:	NULL
Parathyroid	NULL
hormone-like	NULL
peptide	NULL
shares	NULL
features	NULL
with	NULL
members	NULL
of	NULL
the	NULL
early	NULL
response	NULL
gene	NULL
family	NULL
:	NULL
Rapid	NULL
induction	NULL
by	NULL
serum	NULL
,	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
cycloheximide	NULL
.	NULL

Cancer	NULL
Res	NULL
52:3103	NULL
,	NULL
1992	NULL
45	NULL
.	NULL

Jeang	NULL
K-T	NULL
,	NULL
Chiu	NULL
R	NULL
,	NULL
Santos	NULL
E	NULL
,	NULL
Kim	NULL
SJ	NULL
:	NULL
Induction	NULL
of	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
by	NULL
jun	NULL
occurs	NULL
through	NULL
the	NULL
tax-responsive	NULL
21	NULL
{	NULL
-bp	NULL
elements	NULL
.	NULL

Virology	NULL
181:218	NULL
,	NULL
1991	NULL
46	NULL
.	NULL

Rauscher	NULL
FJ	NULL
III	NULL
,	NULL
Morris	NULL
JF	NULL
,	NULL
Tournay	NULL
OE	NULL
,	NULL
Cook	NULL
DM	NULL
,	NULL
Curran	NULL
T	NULL
:	NULL
Binding	NULL
of	NULL
the	NULL
Wilms	NULL
'	NULL
tumor	NULL
locus	NULL
zinc	NULL
finger	NULL
protein	NULL
to	NULL
the	NULL
EGR-1	NULL
consensus	NULL
sequence	NULL
.	NULL

Science	NULL
250:1259	NULL
,	NULL
1990	NULL
EJIMA	NULL
ET	NULL
AL	NULL
47	NULL
.	NULL

Patwardhan	NULL
S	NULL
,	NULL
Gashler	NULL
A	NULL
,	NULL
Siege	NULL
!	NULL

MG	NULL
,	NULL
Chang	NULL
LC	NULL
,	NULL
Joseph	NULL
LJ	NULL
,	NULL
Shows	NULL
TB	NULL
,	NULL
LeBeau	NULL
MM	NULL
,	NULL
Sukhatme	NULL
VP	NULL
:	NULL
EGR3	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
Egr	NULL
family	NULL
of	NULL
genes	NULL
encoding	NULL
immediate-early	NULL
transcription	NULL
fac-tors	NULL
.	NULL

Oncogene	NULL
6:917	NULL
,	NULL
1991	NULL
48	NULL
.	NULL

Wright	NULL
JJ	NULL
,	NULL
Gunter	NULL
KC	NULL
,	NULL
Mitsuya	NULL
H	NULL
,	NULL
Irving	NULL
SG	NULL
,	NULL
Kelly	NULL
K	NULL
,	NULL
Sie-benlist	NULL
U	NULL
:	NULL
Expression	NULL
of	NULL
a	NULL
zinc	NULL
finger	NULL
gene	NULL
in	NULL
HTLV-I	NULL
and	NULL
HTLV-II	NULL
transformed	NULL
cells	NULL
.	NULL

Science	NULL
248:588	NULL
,	NULL
1990	NULL
49	NULL
.	NULL

Madden	NULL
SL	NULL
,	NULL
Cook	NULL
DM	NULL
,	NULL
Morris	NULL
JF	NULL
,	NULL
Gashler	NULL
A	NULL
,	NULL
Sukhatme	NULL
VP	NULL
,	NULL
Rauscher	NULL
FJ	NULL
III	NULL
:	NULL
Transcription	NULL
repression	NULL
mediated	NULL
by	NULL
the	NULL
WTI	NULL
Wilms	NULL
tumor	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
253:1550	NULL
,	NULL
1991	NULL
50	NULL
.	NULL

Gitlin	NULL
SD	NULL
,	NULL
Bosselut	NULL
R	NULL
,	NULL
Gegonne	NULL
A	NULL
,	NULL
Ghysdael	NULL
J	NULL
,	NULL
Brady	NULL
JN	NULL
:	NULL
Sequence-specific	NULL
interaction	NULL
of	NULL
the	NULL
Ets	NULL
!	NULL

protein	NULL
with	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J	NULL
Virol	NULL
65	NULL
:	NULL
5513	NULL
,	NULL
1992	NULL
51	NULL
.	NULL

Pozzatti	NULL
R	NULL
,	NULL
Vogel	NULL
J	NULL
,	NULL
Jay	NULL
G	NULL
:	NULL
The	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
gene	NULL
can	NULL
cooperate	NULL
with	NULL
the	NULL
ras	NULL
oncogene	NULL
to	NULL
induce	NULL
neoplastic	NULL
transformation	NULL
of	NULL
cells	NULL
,	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:413	NULL
,	NULL
1990	NULL
52	NULL
.	NULL

Smith	NULL
MR	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
tax	NULL
protein	NULL
transforms	NULL
rat	NULL
fibroblasts	NULL
through	NULL
the	NULL
cyclic	NULL
adenosine	NULL
monophosphate	NULL
:	NULL
Response	NULL
element	NULL
binding	NULL
protein/activating	NULL
transcription	NULL
factor	NULL
pathway	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
88:1038	NULL
,	NULL
1991	NULL
From	NULL
www	NULL
.	NULL

by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1993	NULL
81	NULL
:	NULL
1017-1024	NULL
Cell-type-specific	NULL
transactivation	NULL
of	NULL
the	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
gene	NULL
promoter	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
tax	NULL
and	NULL
HTLV-II	NULL
tax	NULL
proteins	NULL
E	NULL
Ejima	NULL
,	NULL
JD	NULL
Rosenblatt	NULL
,	NULL
M	NULL
Massari	NULL
,	NULL
E	NULL
Quan	NULL
,	NULL
D	NULL
Stephens	NULL
,	NULL
CA	NULL
Rosen	NULL
and	NULL
D	NULL
Prager	NULL
A	NULL
_	NULL
?	NULL

_T	NULL
'	NULL
JO	NULL
S	NULL
;	NULL
'	NULL
C	NULL
\se	NULL
@	NULL
.	NULL

@	NULL
&	NULL
&	NULL
@	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/81/4/1017.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

